SIN3A
Basic information
Region (hg38): 15:75369379-75455842
Links
Phenotypes
GenCC
Source:
- autism, susceptibility to, 15 (Strong), mode of inheritance: AD
- chromosome 15q24 deletion syndrome (Strong), mode of inheritance: AD
- SIN3A-related intellectual disability syndrome due to a point mutation (Supportive), mode of inheritance: AD
- congenital diaphragmatic hernia (Limited), mode of inheritance: AD
- chromosome 15q24 deletion syndrome (Strong), mode of inheritance: AD
- SIN3A-related intellectual disability syndrome (Definitive), mode of inheritance: AD
- SIN3A-related intellectual disability syndrome (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Witteveen-Kolk syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 27399968 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (23 variants)
- SIN3A-related intellectual disability syndrome due to a point mutation (13 variants)
- Inborn genetic diseases (8 variants)
- SIN3A-related intellectual disability syndrome (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SIN3A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 118 | 129 | ||||
missense | 185 | 11 | 202 | |||
nonsense | 17 | 24 | ||||
start loss | 0 | |||||
frameshift | 22 | 32 | ||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 8 | |||||
splice region | 2 | 7 | 13 | 4 | 26 | |
non coding | 37 | 10 | 51 | |||
Total | 42 | 28 | 196 | 166 | 18 |
Variants in SIN3A
This is a list of pathogenic ClinVar variants found in the SIN3A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-75371996-C-T | Uncertain significance (Jun 03, 2023) | |||
15-75372002-C-T | Uncertain significance (Jul 01, 2022) | |||
15-75372007-T-C | Uncertain significance (Nov 30, 2022) | |||
15-75372009-GACACGAT-G | SIN3A-related intellectual disability syndrome due to a point mutation | Likely pathogenic (Oct 04, 2022) | ||
15-75372042-G-C | Likely benign (Oct 22, 2023) | |||
15-75372043-G-C | Uncertain significance (Nov 14, 2023) | |||
15-75372063-G-A | Likely benign (Dec 06, 2023) | |||
15-75372066-A-G | Likely benign (Oct 14, 2022) | |||
15-75372068-A-G | Uncertain significance (Sep 01, 2022) | |||
15-75372085-A-G | Uncertain significance (Apr 24, 2022) | |||
15-75372099-G-A | Likely benign (May 01, 2022) | |||
15-75372120-T-C | Likely benign (Oct 03, 2023) | |||
15-75372125-T-C | Inborn genetic diseases | Uncertain significance (May 08, 2024) | ||
15-75372130-C-T | Uncertain significance (Aug 22, 2022) | |||
15-75372131-G-A | Conflicting classifications of pathogenicity (Jan 15, 2024) | |||
15-75372132-G-C | Likely benign (Mar 06, 2018) | |||
15-75372148-G-C | SIN3A-related intellectual disability syndrome due to a point mutation | Conflicting classifications of pathogenicity (Sep 20, 2024) | ||
15-75372158-C-T | Uncertain significance (Dec 28, 2023) | |||
15-75372160-AC-A | Uncertain significance (Jan 05, 2018) | |||
15-75372161-C-T | SIN3A-related intellectual disability syndrome due to a point mutation | Uncertain significance (Jan 12, 2021) | ||
15-75372162-C-G | Inborn genetic diseases | Uncertain significance (Sep 29, 2023) | ||
15-75372165-G-A | Benign (Jul 16, 2023) | |||
15-75372177-C-G | Inborn genetic diseases | Uncertain significance (Aug 26, 2022) | ||
15-75372181-T-C | SIN3A-related intellectual disability syndrome due to a point mutation | Uncertain significance (Mar 19, 2021) | ||
15-75372187-C-T | SIN3A-related intellectual disability syndrome due to a point mutation | Uncertain significance (Jul 29, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SIN3A | protein_coding | protein_coding | ENST00000394947 | 20 | 86464 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 1.04e-10 | 125744 | 0 | 3 | 125747 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.39 | 386 | 717 | 0.538 | 0.0000403 | 8373 |
Missense in Polyphen | 61 | 239.21 | 0.25501 | 2972 | ||
Synonymous | 0.193 | 262 | 266 | 0.985 | 0.0000144 | 2446 |
Loss of Function | 7.50 | 1 | 67.4 | 0.0148 | 0.00000379 | 738 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional repressor. Corepressor for REST. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Also interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. Acts cooperatively with OGT to repress transcription in parallel with histone deacetylation. Involved in he control of the circadian rhythms. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression (By similarity). {ECO:0000250|UniProtKB:Q60520, ECO:0000269|PubMed:12150998}.;
- Pathway
- Huntington,s disease - Homo sapiens (human);Thyroid hormone signaling pathway - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Androgen receptor signaling pathway;Retinoblastoma (RB) in Cancer;MECP2 and Associated Rett Syndrome;TGF-beta Signaling Pathway;Hedgehog Signaling Pathway;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Epigenetic regulation of gene expression;Gene expression (Transcription);mets affect on macrophage differentiation;Generic Transcription Pathway;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Metabolism of lipids;Factors involved in megakaryocyte development and platelet production;RNA Polymerase II Transcription;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Metabolism;AndrogenReceptor;Hemostasis;C-MYB transcription factor network;Transcriptional regulation by RUNX1;Regulation of Telomerase;Signaling events mediated by HDAC Class I;Hedgehog signaling events mediated by Gli proteins;Regulation of nuclear SMAD2/3 signaling
(Consensus)
Recessive Scores
- pRec
- 0.372
Intolerance Scores
- loftool
- rvis_EVS
- -1.39
- rvis_percentile_EVS
- 4.27
Haploinsufficiency Scores
- pHI
- 0.925
- hipred
- Y
- hipred_score
- 0.786
- ghis
- 0.620
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sin3a
- Phenotype
- normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;in utero embryonic development;activation of innate immune response;positive regulation of defense response to virus by host;hematopoietic progenitor cell differentiation;DNA replication;protein deacetylation;aging;regulation of hormone levels;positive regulation of G2/M transition of mitotic cell cycle;histone deacetylation;regulation of lipid metabolic process;positive regulation of chromatin silencing;cellular protein localization;negative regulation of circadian rhythm;negative regulation of apoptotic process;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;regulation of megakaryocyte differentiation;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;rhythmic process;response to methylglyoxal;cellular response to glucose stimulus;negative regulation of protein localization to nucleus;negative regulation of histone H3-K27 acetylation;cellular response to dopamine;negative regulation of transcription regulatory region DNA binding
- Cellular component
- kinetochore;chromatin;nucleus;nucleoplasm;transcription factor complex;nucleolus;Sin3 complex;transcriptional repressor complex
- Molecular function
- transcription regulatory region sequence-specific DNA binding;RNA polymerase II activating transcription factor binding;RNA polymerase II repressing transcription factor binding;chromatin binding;DNA-binding transcription factor activity;transcription corepressor activity;RNA binding;histone deacetylase activity;protein binding;protein deacetylase activity;protein-containing complex binding